Influence of a novel radiopacifier (nano-sized strontia particles) on in vitro properties of a PMMA bone cement for use in total joint replacements
by Gladius Lewis, Mark R. Towler, Seamus Madigan, Matthew J. German
International Journal of Nano and Biomaterials (IJNBM), Vol. 3, No. 1, 2010

Abstract: In literature reports on strontia-containing PMMA bone cements, the strontia was combined with another material, micron-sized particles were used and in vitro fatigue data are sparse. The present report is on the in vitro characterisation of a strontia-containing PMMA bone cement in which nano-sized strontia particles that were not combined with any other material were used (NANOSRO cement). Compared to the control cement (a commercially-based cement brand with the same composition as that of NANOSRO cement, except that the radiopacifier was BaSO₄), NANOSRO cement had significantly higher radiopacity, lower polymerisation rate at 37°C and longer fatigue life. With regard to setting time, maximum exotherm temperature and compressive strength, the values for both cements were within the limits stipulated in the relevant testing standards. These results suggest that NANOSRO cement has promise for use in anchoring total joint replacements and, therefore, should be studied further.

Online publication date: Tue, 19-Oct-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nano and Biomaterials (IJNBM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com